MEDIA

Caregiver Profile

Caregiver Profile

Meet Dr. Michael A. Ferguson

EDUCATION

Undergraduate Degree

  • St. Lawrence University , 1992 , Canton , NY

Medical School

  • University of Vermont College of Medicine , 2001 , Burlington , VT

Internship

Pediatrics
  • University of Vermont/Fletcher Allen Health Care , 2002 , Burlington , VT

Residency

Pediatrics
  • University of Vermont/Fletcher Allen Health Care , 2004 , Burlington , VT

Residency

Chief Resident in Pediatrics
  • University of Vermont/Fletcher Allen Health Care , 2005 , Burlington , VT

Fellowship

Pediatric Nephrology
  • Boston Children's Hospital , 2008 , Boston , MA

CERTIFICATIONS

  • American Board of Pediatrics, General Pediatrics
  • American Board of Pediatrics, Pediatric Nephrology

PUBLICATIONS

Publications powered by Harvard Catalyst Profiles

  1. Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations. Am J Hum Genet. 2020 10 01; 107(4):727-742. View abstract
  2. Correction to: Prospective pediatric study comparing glomerular filtration rate estimates based on motion-robust dynamic contrast-enhanced magnetic resonance imaging and serum creatinine (eGFR) to 99mTc DTPA. Pediatr Radiol. 2020 May; 50(5):755-756. View abstract
  3. Prospective pediatric study comparing glomerular filtration rate estimates based on motion-robust dynamic contrast-enhanced magnetic resonance imaging and serum creatinine (eGFR) to 99mTc DTPA. Pediatr Radiol. 2020 05; 50(5):698-705. View abstract
  4. Risk Factors for Mortality in Critically Ill Children Requiring Renal Replacement Therapy. Pediatr Crit Care Med. 2019 11; 20(11):1069-1077. View abstract
  5. Renal replacement therapy in the pediatric cardiac intensive care unit. J Thorac Cardiovasc Surg. 2019 11; 158(5):1446-1455. View abstract
  6. Whole-Exome Sequencing Identifies Causative Mutations in Families with Congenital Anomalies of the Kidney and Urinary Tract. J Am Soc Nephrol. 2018 09; 29(9):2348-2361. View abstract
  7. Should ACE inhibitors and ARBs be used in combination in children? Pediatr Nephrol. 2019 09; 34(9):1521-1532. View abstract
  8. African trypanosomes evade immune clearance by O-glycosylation of the VSG surface coat. Nat Microbiol. 2018 08; 3(8):932-938. View abstract
  9. Mesenteric Artery Growth Improves Circulation (MAGIC) in Midaortic Syndrome. Ann Surg. 2018 06; 267(6):e109-e111. View abstract
  10. Whole Exome Sequencing Reveals a Monogenic Cause of Disease in ˜43% of 35 Families With Midaortic Syndrome. Hypertension. 2018 04; 71(4):691-699. View abstract
  11. Tissue expander-stimulated lengthening of arteries for the treatment of midaortic syndrome in children. J Vasc Surg. 2018 06; 67(6):1664-1672. View abstract
  12. The authors reply. Pediatr Crit Care Med. 2017 12; 18(12):1191. View abstract
  13. Whole Exome Sequencing of Patients with Steroid-Resistant Nephrotic Syndrome. Clin J Am Soc Nephrol. 2018 01 06; 13(1):53-62. View abstract
  14. Whole exome sequencing frequently detects a monogenic cause in early onset nephrolithiasis and nephrocalcinosis. Kidney Int. 2018 01; 93(1):204-213. View abstract
  15. Analysis of 24 genes reveals a monogenic cause in 11.1% of cases with steroid-resistant nephrotic syndrome at a single center. Pediatr Nephrol. 2018 02; 33(2):305-314. View abstract
  16. Catheter-Directed Thrombolysis in a Child with Bilateral Renal Artery Graft Thrombosis. J Vasc Interv Radiol. 2017 Aug; 28(8):1184-1188. View abstract
  17. Acute Kidney Injury After Pediatric Cardiac Surgery: A Secondary Analysis of the Safe Pediatric Euglycemia After Cardiac Surgery Trial. Pediatr Crit Care Med. 2017 Jul; 18(7):638-646. View abstract
  18. The effect of an electronic health record-based tool on abnormal pediatric blood pressure recognition. Congenit Heart Dis. 2017 Jul; 12(4):484-490. View abstract
  19. In-Clinic Blood Pressure Prediction of Normal Ambulatory Blood Pressure Monitoring in Pediatric Hypertension Referrals. Congenit Heart Dis. 2016 Jul; 11(4):309-14. View abstract
  20. Mutations in SLC26A1 Cause Nephrolithiasis. Am J Hum Genet. 2016 06 02; 98(6):1228-1234. View abstract
  21. Increased platelet mitochondrial respiration after cardiac arrest and resuscitation as a potential peripheral biosignature of cerebral bioenergetic dysfunction. J Bioenerg Biomembr. 2016 06; 48(3):269-79. View abstract
  22. Evaluation and treatment of hypertensive crises in children. Integr Blood Press Control. 2016; 9:49-58. View abstract
  23. Prevalence of Monogenic Causes in Pediatric Patients with Nephrolithiasis or Nephrocalcinosis. Clin J Am Soc Nephrol. 2016 Apr 07; 11(4):664-72. View abstract
  24. In vitro generation of human pluripotent stem cell derived lung organoids. Elife. 2015 Mar 24; 4. View abstract
  25. Commentary on "protective effect of pulmonary hypertension against right-sided tamponade in pericardial effusion". South Med J. 2015 Jan; 108(1):49-50. View abstract
  26. Evaluation of the diagnostic accuracy of prototype rapid tests for human African trypanosomiasis. PLoS Negl Trop Dis. 2014 Dec; 8(12):e3373. View abstract
  27. Lead optimization of a pyrazole sulfonamide series of Trypanosoma brucei N-myristoyltransferase inhibitors: identification and evaluation of CNS penetrant compounds as potential treatments for stage 2 human African trypanosomiasis. J Med Chem. 2014 Dec 11; 57(23):9855-69. View abstract
  28. Serum proteome of nonalcoholic fatty liver disease: a multimodal approach to discovery of biomarkers of nonalcoholic steatohepatitis. J Gastroenterol Hepatol. 2014 Oct; 29(10):1839-47. View abstract
  29. Cost effectiveness of percutaneous closure versus medical therapy for cryptogenic stroke in patients with a patent foramen ovale. Am J Cardiol. 2014 Nov 15; 114(10):1584-9. View abstract
  30. Percutaneous closure versus medical therapy alone for cryptogenic stroke patients with a patent foramen ovale: meta-analysis of randomized controlled trials. Tex Heart Inst J. 2014 Aug; 41(4):357-67. View abstract
  31. Identification of sVSG117 as an immunodiagnostic antigen and evaluation of a dual-antigen lateral flow test for the diagnosis of human African trypanosomiasis. PLoS Negl Trop Dis. 2014 Jul; 8(7):e2976. View abstract
  32. Proteomic selection of immunodiagnostic antigens for Trypanosoma congolense. PLoS Negl Trop Dis. 2014 Jun; 8(6):e2936. View abstract
  33. Clinical predictors and impact of ambulatory blood pressure monitoring in pediatric hypertension referrals. J Am Soc Hypertens. 2014 Sep; 8(9):660-7. View abstract
  34. Midaortic syndrome: 30 years of experience with medical, endovascular and surgical management. Pediatr Nephrol. 2013 Oct; 28(10):2023-33. View abstract
  35. Rational use of antihypertensive medications in children. Pediatr Nephrol. 2014 Jun; 29(6):979-88. View abstract
  36. High-dose ibuprofen is not associated with increased biomarkers of kidney injury in patients with cystic fibrosis. Pediatr Pulmonol. 2014 Feb; 49(2):148-53. View abstract
  37. Aorto-mesenteric and renal allograft transplant: a novel treatment for midaortic syndrome. Am J Transplant. 2013 Apr; 13(4):1088-1092. View abstract
  38. A novel treatment for the midaortic syndrome. N Engl J Med. 2012 Dec 13; 367(24):2361-2. View abstract
  39. Mild postoperative acute kidney injury and outcomes after surgery for congenital heart disease. J Thorac Cardiovasc Surg. 2013 Jul; 146(1):146-52. View abstract
  40. Fulminant thrombotic microangiopathy in pediatrics: where diagnostic and therapeutic dilemmas meet. Am J Hematol. 2012 Aug; 87(8):816-8. View abstract
  41. Established and emerging markers of kidney function. Clin Chem. 2012 Apr; 58(4):680-9. View abstract
  42. Urinary liver-type fatty acid-binding protein predicts adverse outcomes in acute kidney injury. Kidney Int. 2010 Apr; 77(8):708-14. View abstract
  43. Urinary biomarkers for sensitive and specific detection of acute kidney injury in humans. Clin Transl Sci. 2008 Dec; 1(3):200-8. View abstract
  44. Biomarkers of nephrotoxic acute kidney injury. Toxicology. 2008 Mar 20; 245(3):182-93. View abstract
  45. Biomarkers of acute kidney injury. Annu Rev Pharmacol Toxicol. 2008; 48:463-93. View abstract
  46. Comparison of Fy(b) status as determined serologically and genetically. Transfus Med. 1997 Jun; 7(2):135-41. View abstract